Cutaneous Manifestations in Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy: A Comprehensive Review

January 2024 in “ Biomedicines ”

Florica Șandru, Răzvan Petca, Mihai Cristian Dumitraşcu, Aida Petca, Ana-Maria Ionescu, Livia-Cristiana Băicoianu-Nițescu

alopecia areata chronic mucocutaneous candidiasis vitiligo AIRE gene IL-17 autoantibodies type I interferons Th17-associated cytokines AA CMC

Studysummary This review discussed the cutaneous manifestations of APECED, highlighting chronic mucocutaneous candidiasis, alopecia areata, and vitiligo, while emphasizing the importance of early detection and monitoring for accurate diagnosis and patient care in various populations.

Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer

The review on Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED) highlights the significant cutaneous manifestations, including chronic mucocutaneous candidiasis (CMC), alopecia areata (AA), and vitiligo, with varying prevalence rates across different populations. It emphasizes the importance of early detection and comprehensive monitoring of these symptoms for better patient care. The review also discusses the genetic underpinnings, particularly mutations in the AIRE gene, and the role of IL-17-mediated immunity in the pathogenesis of APECED. The presence of autoantibodies against type I interferons and Th17-associated cytokines is noted as a significant diagnostic marker. The review calls for further research to understand the genotype-phenotype relationship and improve patient care, highlighting the need for a multidisciplinary approach due to the complex interplay between endocrine and dermatological symptoms.

View this study on mdpi.com →

Discuss this study in the Community →

Research cited in this study

11 / 11 results

research Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients With APS-1

2 citations , December 2023 in “Journal of clinical immunology”

This study describes the positive effects of the JAK inhibitor ruxolitinib in treating autoimmune manifestations in three patients with autoimmune polyendocrine syndrome type-1 over a period of at least 30 months, with excellent tolerance and no adverse events observed.

research Beard Alopecia: An Updated and Comprehensive Review of Etiologies, Presentation and Treatment

1 citations , July 2023 in “Journal of Clinical Medicine”

This review provides a detailed overview of the causes, prevalence, pathophysiology, clinical presentation, and treatment of beard alopecia, highlighting conditions such as alopecia areata, pseudofolliculitis barbae, and tinea barbae, and aims to serve as a resource for clinicians handling such cases.

research Differential Impact of Environmental Factors on Systemic and Localized Autoimmunity

5 citations , May 2023 in “Frontiers in immunology”

This review discusses how environmental factors like lifestyle, nutrition, and vitamin deficiencies may influence autoimmune diseases such as MS, SLE, and AA, highlighting associations with vitamin D levels and dietary interventions, but notes a lack of conclusive evidence for their roles in disease pathogenesis.

research Autoimmune Polyendocrine Syndrome Type 1: An Italian Survey on 158 Patients

31 citations , May 2021 in “Journal of endocrinological investigation”

This study in Italy found that APS-1, a rare disorder, is associated with various AIRE gene mutations and most individuals have autoantibodies such as IFNωAbs, which are markers of the condition.

research Hypoparathyroidism as the Single Major Component for Decades of Autoimmune Polyglandular Syndrome Type 1

2 citations , December 2020 in “Endocrinology, diabetes & metabolism case reports”

This case study highlights the complexity of managing autoimmune polyglandular syndrome type 1, emphasizing the need for thorough clinical history, high suspicion for early diagnosis, and continuous long-term follow-up.

research Alopecia Areata: A Review of Disease Pathogenesis

191 citations , May 2018 in “British journal of dermatology/British journal of dermatology, Supplement”

This study reviewed recent theories on alopecia areata's pathogenesis, highlighting its autoimmune nature due to immune privilege disruption in hair follicles, and noted current treatments have limited efficacy with high relapse rates, underscoring the need for further research into its mechanisms for better therapies.

research Dermatologic Manifestations of Endocrine Disorders

86 citations , October 2017 in “Translational pediatrics”

This review discusses how ophthalmic findings can reveal key endocrine disorders and reports no new clinical results, emphasizing the eye's role in diagnosing and managing systemic diseases like diabetes and Graves' ophthalmopathy.

research Alopecia Areata of the Beard: A Review of the Literature

16 citations , May 2017 in “American Journal of Clinical Dermatology”

This review discusses the clinical features, diagnosis, and treatment options for alopecia areata of the beard and reports no new clinical results.

research Beard Alopecia Areata: A Multicenter Review of 55 Patients

17 citations , August 2016 in “JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology”

This study reported that 45.5% of patients with beard alopecia areata progressed to scalp alopecia areata within at least 12 months, with most cases occurring during the first year.

research Vitiligo: A Comprehensive Overview

532 citations , August 2011 in “Journal of the American Academy of Dermatology”

This article discusses the clinical presentation, histopathologic findings, and pathogenesis hypotheses of vitiligo without reporting new clinical results.

research Role of the Autoimmune Regulator (AIRE) Gene in Alopecia Areata: Strong Association of a Potentially Functional AIRE Polymorphism With Alopecia Universalis

86 citations , December 2002 in “Tissue Antigens”

In this study, researchers found that the AIRE G961C variant is a significant risk factor for severe alopecia areata and early-onset cases, particularly in patients with alopecia universalis.